Together, our findings identify and delineate an androgen-/AR-regulated signaling axis that drives melanoma malignancy, reinforcing melanoma as a sex-associated cancer and highlighting new therapeutic opportunities for the clinical management of melanoma invasiveness. Here, AR is linked to cancer.